Chemotherapy in the management of ovarian carcinoma: a review.
作者信息
Malpas J S
出版信息
J R Soc Med. 1979 May;72(5):357-61.
Abstract
摘要
相似文献
1
Chemotherapy in the management of ovarian carcinoma: a review.
J R Soc Med. 1979 May;72(5):357-61.
2
Present optimal therapy in ovarian cancer.
Eur J Cancer Clin Oncol. 1986 Jan;22(1):9-12. doi: 10.1016/0277-5379(86)90336-6.
3
Chemotherapy of ovarian cancer.
Surg Clin North Am. 1978 Feb;58(1):143-50. doi: 10.1016/s0039-6109(16)41441-6.
4
Chemotherapy of ovarian cancer: past and present.
Semin Oncol. 1975 Sep;2(3):267-76.
5
Epithelial carcinoma of the ovary: current strategies.
Ann Intern Med. 1981 Jul;95(1):98-111. doi: 10.7326/0003-4819-95-1-98.
6
[Chemotherapy of the ovarian carcinoma (author's transl)].
Strahlentherapie. 1977 May;153(5):325-30.
7
Current status of chemotherapy for ovarian carcinoma.
Eur J Cancer Clin Oncol. 1988 Apr;24(4):583-5. doi: 10.1016/0277-5379(88)90284-2.
8
Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5.
Radiother Oncol. 1984 Jun;2(1):19-29. doi: 10.1016/s0167-8140(84)80034-1.
9
Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents.
Cancer Treat Rep. 1979 Jan;63(1):137-8.
10
[Chemotherapy of advanced epithelial ovarian carcinoma].
Onkologie. 1984 May;7 Suppl 2:22-34. doi: 10.1159/000215512.
引用本文的文献
1
Predicting Response to Anthracyclines in Ovarian Cancer.
Int J Environ Res Public Health. 2022 Apr 2;19(7):4260. doi: 10.3390/ijerph19074260.
2
The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Mol Med. 2011;17(11-12):1262-74. doi: 10.2119/molmed.2011.00176. Epub 2011 Aug 19.
3
Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas.
PLoS One. 2007 May 16;2(5):e441. doi: 10.1371/journal.pone.0000441.
本文引用的文献
1
The role of chemotherapy in the treatment of gynecologic malignancy.
Am J Obstet Gynecol. 1965 Dec 15;93(8):1102-11. doi: 10.1016/0002-9378(65)90179-1.
2
Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
Can Med Assoc J. 1968 Mar 16;98(11):539-41.
3
Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
Cancer Chemother Rep. 1972 Aug;56(4):505-14.
4
Cyclophosphamide in the treatment of ovarian cancer.
Clin Obstet Gynecol. 1968 Jun;11(2):382-400. doi: 10.1097/00003081-196806000-00001.
5
Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series.
Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):136-41.
6
Chemotherapy of ovarian cancer. New approaches to treatment.
Cancer. 1972 Dec;30(6):1565-71. doi: 10.1002/1097-0142(197212)30:6<1565::aid-cncr2820300623>3.0.co;2-h.
7
Chemotherapy in the treatment of cancer of the ovary.
Am J Obstet Gynecol. 1970 Jul 1;107(5):691-703. doi: 10.1016/s0002-9378(16)33987-4.
8
Treatment of ovarian cancer with thiotepa.
Clin Obstet Gynecol. 1968 Jun;11(2):428-38.
9
Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy.
Am J Obstet Gynecol. 1970 Nov 15;108(6):878-88.
10
Understanding the problem of understaging in ovarian cancer.
Semin Oncol. 1975 Sep;2(3):235-42.
Zotero 插件